Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating CEA Positive Rectal Cancer

NCT02403505 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Rectal Cancer

Interventions

BIOLOGICAL: CEA protein antigen plus BCG Vaccine Mix for percutaneous use

Sponsor

Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair

Collaborators

[object Object]